Hugh M Cole
CIK 1604646 · Chief Operating Officer · last filed 2026-01-23
Hugh M Cole is a Chief Operating Officer who has filed 32 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for ATXS, was dated Jan 23, 2026. Across all open-market trades the lifetime net is −$410.5K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
32
-$410.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. (ATXS) Delisted | Director | — | $12.58 | — | $0 | 6 | 2026-01-23 |
| Jounce Therapeutics, Inc. (JNCE) Delisted | Chief Operating Officer | 119,264 | $1.88 | $224.2K | -$368.1K | 16 | 2023-01-11 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | — | $8.54 | — | $0 | 3 | 2021-06-02 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | SVP, Chief Business Officer | 0 | — | — | -$42.4K | 7 | 2017-02-16 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-23 | Astria Therapeutics, Inc. (ATXS) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-12 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-06 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-11 | Jounce Therapeutics, Inc. (JNCE) Delisted | Sell (S) | −16,634 | -$18.5K | EDGAR |
| 2022-08-03 | Jounce Therapeutics, Inc. (JNCE) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2022-06-21 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-17 | Jounce Therapeutics, Inc. (JNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-03 | Jounce Therapeutics, Inc. (JNCE) Delisted | Grant (A) | +42,500 | $0 | EDGAR |